跳至主要内容
临床试验/NCT04310631
NCT04310631已完成不适用

Optical Coherence Tomography Angiography Findings After Intravitreal Ranibizumab in Patients With Coats Disease

Federico II University1 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2016年1月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
5
试验地点
1
主要终点
Study of retinal and vascular features in Coats disease after intravitreal injections of Ranibizumab

研究概览

简要总结

This study evaluates the retinal and vascular features in patients affected by Coats disease under the effects of Ranibizumab intravitreal injections using optical coherence tomography and optical coherence tomography angiography

详细描述

Coats disease is an idiopathic retinal vascular disorder, occurs in young males, and is characterized by retinal telangiactasias, numerous yellowish exudates in the subretinal space, macular edema, hemorrhages and, in advanced end-stage, by exudative retinal detachment.

Ranibizumab is a vascular endothelial growth factor antagonist represent an efficacy treatment acting on vascular hyperpermeability. The optical coherence tomography and optical coherence tomography angiography represent novel and non-invasive diagnostic techniques that allow a detailed analysis of retinal and vascular features. The study evaluates the changes in optical coherence tomography and optical coherence tomography angiography parameters at baseline and after three monthly injections of Ranibizumab in Coats disease.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
19 Years 至 30 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • age older than 18 years
  • diagnosis of Coats disease
  • treatment-naïve with Ranibizumab
  • absence of other vitreoretinal and vascular retinal diseases
  • absence of diabetes

排除标准

  • age younger than 18 years
  • No diagnosis of Coats disease
  • previous treatments with Ranibizumab
  • presence of vitreoretinal and vascular retinal diseases
  • presence of diabetes

结局指标

主要结局

Study of retinal and vascular features in Coats disease after intravitreal injections of Ranibizumab

时间窗: Three months

The effectiveness of Ranibizumab injections for treating Coats disease using optical coherence tomography angiography (OCTA) The parameters analyzed by OCTA were: retinal vessel density (%), choriocapillaris vessel density (%)

次要结局

未报告次要终点

研究者

发起方
Federico II University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Gilda Cennamo

Principal Investigator

Federico II University

研究点 (1)

Loading locations...

相似试验